Catalent, facing pressure from Elliott, had other activists in stock

By Svea Herbst-Bayliss NEW YORK (Reuters) - Contract drugmaker Catalent, which is being pushed to make changes to its board by Elliott Investment ...

Related Keywords

United States ,Keith Meister Corvex ,Sonali Paul ,Svea Herbst Bayliss ,Astrazeneca ,Johnson ,Reuters ,Elliott Investment Management ,Corvex Management ,Scott Ferguson ,Sachem Head Capital Management ,Sachem Head ,